Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma - Concepedia

Concepedia

Publication | Open Access

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

DOI Full Paper Access

66

Citations

22

References

2022

Year

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen, Bin Xu, Ningling Ge, Yuan Ji, Xu-Dong Qu, Lingli Chen, Yi Chen, Meiling Li,

Annals of Surgical Oncology

References

	Year	Citations

Page 1